A recent study in melanoma cells showed that increased expression of PTENP1-AS resulted in the induction of BRAF inhibitor resistant cells and is likely to be due to the recruitment of epigenetic modifiers to the PTEN promoter region, resulting in reduced PTEN expression [151]. This evidence concerns the gene PTEN and melanoma.